As a leader in ZS’s value and access practice, Kyle partners with pharma companies to help them provide patients sustainable and affordable access to their medications. His teams solve some of pharma’s most challenging business problems by leveraging their exceptional command of data and deep understanding of the economic and business dynamics that drive healthcare.

Kyle is a passionate leader in U.S. value and access within the biopharma industry, with extensive experience leveraging big data, analytics and technology to provide actionable insights and support strategic decision-making. His deep expertise across U.S. market access and policy, gross-to-net optimization and patient support allows him to bring a unique perspective to his partners in the pharma industry.

Before joining ZS, Kyle led the legacy Amundsen Consulting practice within IQVIA’s market access center of excellence. He also spent 10 years providing strategic support for market access, policy, patient support and finance teams within biopharma organizations. Previously, he spent three years at Decision Resources Group.

Kyle holds a B.S. in biochemistry from Boston College.